Navigation Links
GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel

GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's vaccine technology is covered by 20 issued or filed patent applications. GeoVax HIV/AIDS vaccines are designed to prevent development of Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, by vaccinating individuals prior to infection with the AIDS virus. In addition, GeoVax AIDS vaccines may be effective as therapeutics (treatment of people infected with AIDS virus). Studies evaluating these vaccines in already HIV/AIDS infected individuals are being planned.

GeoVax DNA and Recombinant MVA HIV/AIDS vaccines:

-- Use DNA vaccines to "prime" immune responses and MVA vaccines to

"boost" immune responses against the AIDS virus

-- Express more than 50% of AIDS virus components in vaccinees and can

not cause AIDS

-- Protected 22 of 23 (96%) non-human primates against development of

AIDS for over 3 1/2 years

-- Are manufactured & tested under GMP/GLP - EMEA (EU) and FDA guidelines

-- Satisfactorily completed 2 earlier DNA & DNA/MVA -- HIV/AIDS vaccine

Phase 1 human trials

-- Are currently being tested in 3 Human Trials. One started in 2006, two

in summer 2007

-- Have been demonstrated safe to date in human trials

-- Are demonstrating positive immune responses against HIV in the

majority of vaccine recipients

-- Are in planning stage for larger Phase 2 human trial in 2008

About Financial Relations Board

For more than 40 years, the Financial Relations Board has been one of the nation's leaders for investor relations and financial communications. The firm offers a full array of services, including deep expertise in corporate positioning and communication, investment

SOURCE GeoVax Labs, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
11. Biopure Announces 2007 Third Quarter Financial Results
Post Your Comments:
(Date:6/2/2015)... DUBLIN , June 02, 2015 Research ... of the "Europe Fluoroscopy Market - Growth, Trends ... offering. The European market for Fluoroscopy is ... to 2020 Fluoroscopy is used to view ... catheter through blood vessels, bile ducts or the urinary ...
(Date:6/2/2015)... June 02, 2015 Research and Markets ... the "Laboratory Centrifuges - Global Strategic Business ... Annual estimates and forecasts are provided for the ... analysis is provided for these markets. Market data ... research. Company profiles are primarily based on public ...
(Date:6/2/2015)... -- Research and Markets ( ) has announced the ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... the period 2014 through 2020. Also, a seven-year historic analysis ...
Breaking Medicine Technology:European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
... 2012 Lilly Diabetes today announced a donation of ... The contribution will support the Foundation,s mission to empower ... lives to the fullest. The Foundation will use the ... 1 diabetes as well as conference scholarships for families ...
... April 3, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... District Court for the District of Delaware has ruled ... 7,410,978 (the ,978 Patent), 7,759,359 (the ,359 Patent), 7,781,448 ... (the ,635 Patent) for Sanctura XR® (trospium chloride extended-release ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit 2
(Date:6/2/2015)... Concorde Career Colleges, Inc., announced today the appointment ... manage day-to-day operations for the privately held career college ... to help our Concorde team deliver on our commitment ... part due to reports like Beyond College Rankings from ... and Portland.” , Bell brings 14 years of executive ...
(Date:6/2/2015)... On March 19th, 2015, held ... Hall of Legends at Detroit’s Ford Field. Hosted by ... Moore, the goal of the conference was to raise ... highlight the benefits of effective professional rehabilitation programs. It ... options that are available to them in regards to ...
(Date:6/2/2015)... Phoenix, AZ (PRWEB) June 02, 2015 The ... encouraged viewers to watch the station’s 6:00 a.m. Good Morning ... be entered on the station’s Facebook page. , ... other code-entering participants. She plans to apply the monthly ... months. Allen, a stay-at-home mom, expressed her surprise and ...
(Date:6/2/2015)... June 02, 2015 Bitscape Infotech today ... 2015 Microsoft Worldwide Small and Midsized Cloud Solutions Award. ... top Microsoft partners for demonstrating excellence in innovation and ... , “This comes as no surprise to us as ... year consecutively at worldwide level by Microsoft. We will ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Milton Hershey ... one of the 30 members of the Physician Assistant ... of Medicine. He was presented with a white coat, ... , “We are extremely proud of Vincent’s accomplishments both ... “He is a great example of how a top-notch ...
Breaking Medicine News(10 mins):Health News:Concorde Career Colleges Announces New President and COO 2Health News:Rehabilitation Facility Graduate Shares Her Story at "Fighting Addiction Together" Conference 2Health News:Scottsdale Resident Named $12,000 Prize Winner- Arizona Central and KTVK 3TV Phoenix Partner in Mortgage Giveaway Contest 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3
... ( ), an online investment newsletter ... subscribers with updated coverage of several biotech stocks, including ... GILD ), Celgene (Nasdaq: CELG ... Pharmaceuticals (Nasdaq: VRTX ).All paid and trial ...
... congressman to lead debate on improving patient careWASHINGTON, March ... today announced that Tony Coelho will serve as chairperson ... congressman and primary author of the Americans with Disabilities ... people with disabilities for 40 years."I,m excited about the ...
... national health workforce planningWASHINGTON, March 12 Health system reform cannot be ... policy, Dr. Steven A. Wartman, president and CEO of the Association of ... hearing on W orkforc e ... Hea lth Care Re ...
... Pharmaceutical Research and Manufacturers of America (PhRMA) President and ... the White House health reform summit in Dearborn, Michigan ... offer solutions to the healthcare crisis we are now ... White House health reform summits taking place in Dearborn ...
... in cancer and nutrition are meeting in Zurich, Switzerland ... of the most important and fiercely debated topics in ... , There is growing evidence that many cancers may ... diet. In addition, nutritional problems can also have a ...
... a.m. EST, March 12, 2009) People over 80 years ... do not appear to benefit from most commonly prescribed heart ... Institute and published in the March 15 issue of The ... continues to live longer lives, often surviving with heart failure ...
Cached Medicine News:Health Updates Outlook on Biotech Stocks 2Health News:Tony Coelho is Named New Chair of Coalition for Comparative Effectiveness Research 2Health News:Health Reform Must Include Health Workforce, AAHC President Tells Congress 2Health News:White House Healthcare Summit Offers Opportunity for Input Into Reform 2Health News:White House Healthcare Summit Offers Opportunity for Input Into Reform 3Health News:New data on link between cancer and nutrition discussed at European symposium 2Health News:Older patients with 1 type of heart failure may receive little or no benefit from drugs 2
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... involved in the control of the growth ... which synthesize and secrete male and female ... FSH is controlled by these sex hormones ... FSH Quantitative Test Kit is based on ...
... Our Class II Direct to High Res SSP kits ... a single tray. Locus specific typing on a single ... , Straight from genomic DNA to high resolution ... Allele level typing with a single tray , Unique ...
... to High Res SSP kits provide high resolution typing ... specific typing on a single tray reduces QC and ... genomic DNA to high resolution results, no need for ... a single tray , Unique reaction pattern for most ...
Medicine Products: